|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.48 USD | +1.85% |
|
+0.38% | +5.86% |
| 01:48pm | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| 01:03pm | Merck, CEPI Collaborate on More Affordable Ebola Vaccine | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$114.59 | +4.7% | 27 | ||||||
| US$1,110.72 | +6.67% | 28 | ||||||
| US$212 | -2.85% | 24 | ||||||
| US$245.22 | +14.57% | 27 | ||||||
| CHF 342.27 | -1.08% | 19 | ||||||
| GBX 204.34 | +12.25% | 20 | ||||||
| CHF 139.43 | -3.64% | 20 | ||||||
| DKK 400.99 | +2.95% | 21 | ||||||
| US$331.59 | +0.18% | 27 | ||||||
| US$134.42 | +8.28% | 26 | ||||||
| US$28.66 | +12.29% | 24 | ||||||
| US$500.4 | +13.19% | 25 | ||||||
| €100.96 | +29.39% | 22 | ||||||
| US$56.96 | +5.05% | 23 | ||||||
| GBX 18.73 | +4.3% | 19 | ||||||
| JP¥8,892.86 | +7.88% | 14 | ||||||
| CN¥82.86 | +36.96% | 17 | ||||||
| JP¥5,103.07 | +0.81% | 15 | ||||||
| €40.98 | -4.52% | 20 | ||||||
| Average | 950.58 | +7.76% | 22 | ||||||
| Weighted average by Cap. | 625.47 | +5.77% | 24 |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition